awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39090350-E7A23B72-8FB4-47B8-B410-2E248627B2ED
Q39090350-E7A23B72-8FB4-47B8-B410-2E248627B2ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39090350-E7A23B72-8FB4-47B8-B410-2E248627B2ED
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study.
P2860
Q39090350-E7A23B72-8FB4-47B8-B410-2E248627B2ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39090350-E7A23B72-8FB4-47B8-B410-2E248627B2ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e962cfe40c5ee0e3ce089666404372666a9030b6
P2860
A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers